Biogen shares fall after optic nerve study results seen as mixed

January 8, 2015 3:41 PM

5 0

Biogen shares fall after optic nerve study results seen as mixed

Republic Day 2015 rehearsals

(Reuters) - Biogen Idec Inc said an experimental drug showed evidence of biological repair of the optic nerve in patients with acute inflammation of the optic nerve, but shares fell as analysts wondered how promising the mid-stage study results were.

Also read: Trump Has Already Betrayed The Working Class

Read more

To category page

Loading...